Dr. Kui Li earned his medical and PhD degrees from Beijing Medical University (currently Peking University Health Science Center) and received postdoctoral training at the University of Texas Medical Branch (UTMB). He was appointed Research Assistant Professor in 2003 followed by Assistant Professor on the tenure-track in 2005 in the Microbiology and Immunology department at UTMB. In 2008, Dr. Li joined the Department of Microbiology, Immunology and Biochemistry (formerly Department of Molecular Sciences) at the University of Tennessee Health Science Center as Associate Professor and was awarded tenure in 2010. He is promoted to full professor effective July 1, 2014. Dr. Li’s research is aimed at understanding virus-host interactions that control pathogenesis and outcome of RNA virus infections. His work has contributed to knowledge of how hepatitis C virus and related flaviviruses and SARS coronavirus regulate innate immune responses of the host. Dr. Li has published over 60 articles in peer-reviewed international journals including Journal of Virology, JBC, and Hepatology etc. He served on NIH study sections and reviewed grants for funding agencies from Hong Kong, Ireland, Italy and Israel. Dr. Li sits on the editorial boards of PLoS ONE, Virologica Sinica and Chinese Journal of Viral Diseases. He also reviews manuscripts for numerous scientific journals including PNAS, PLoS Pathogens, Hepatology, Gastroenterology, Journal of Virology, Journal of Biological Chemistry, etc.